Condition

Late Onset Alzheimer Disease

ClinicalTrials.gov condition label

Clinical trials6

Recruiting1

Common interventions4

Lead sponsors shown6

Clinical trials

6 shown

Alzheimer's Disease Genetics StudyNCT00064870 · 2002-06-01

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's DiseaseNCT04838301 · 2023-08-15

ACTIVE_NOT_RECRUITING

Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's DiseaseNCT07294586 · 2019-10-28

Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172NCT01222351 · 2010-12-01

Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic PolymorphismsNCT03349320 · 2009-06-01

Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's DiseaseNCT03624842

NO_LONGER_AVAILABLE

Common interventions

AllopregnanoloneDRUG1 BAY 94-9172 (Florbetaben)DRUG1 PlaceboOTHER1 Trappsol (R) Cyclo (TM)DRUG1

Leading sponsors

Amoneta Diagnostics SAS1 Cyclo Therapeutics, Inc.1 Federal University of Minas Gerais1 Indiana University1 New York State Psychiatric Institute1 University of Arizona1

Trial status mix

COMPLETED3

ACTIVE_NOT_RECRUITING1

NO_LONGER_AVAILABLE1

RECRUITING1

Phase mix

NA1

PHASE21

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.